Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 5/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.32 |
| ▸ | KDM4A | O75164 | 1/20 | 0.32 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.32 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 6/20 | 0.32 |
| ▸ | PPARD | Q03181 | 6/20 | 0.32 |
| ▸ | PPARA | Q07869 | 6/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.32 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.32 |
| ▸ | TLR2 | O60603 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | FABP4 | P15090 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1509902 | 0.81 | TSHR (0.35) | FFAR4FFAR1ALDH1A1TSHRLMNA | |
| SCHEMBL736106 | 0.76 | FFAR4 (0.43) | FFAR4FFAR1ALDH1A1GSTK1TSHR | |
| SCHEMBL7905680 | 0.76 | TSHR (0.40) | TSHRSLC22A6 | |
| SCHEMBL1230057 | 0.72 | TSHR (0.48) | FFAR4FFAR1ALDH1A1TSHRLMNA | |
| SCHEMBL20897216 | 0.72 | FFAR4 (0.48) | FFAR4FFAR1ALDH1A1GSTK1TSHR | |
| SCHEMBL23611046 | 0.72 | FFAR4 (0.48) | FFAR4FFAR1ALDH1A1GSTK1TSHR | |
| SCHEMBL905699 | 0.72 | TSHR (0.48) | FFAR4FFAR1ALDH1A1TSHRLMNA | |
| SCHEMBL905720 | 0.72 | TSHR (0.48) | FFAR4FFAR1ALDH1A1TSHRLMNA | |
| SCHEMBL379359 | 0.72 | TSHR (0.48) | FFAR4FFAR1ALDH1A1TSHRLMNA | |
| SCHEMBL14119694 | 0.72 | FFAR4 (0.48) | FFAR4FFAR1ALDH1A1GSTK1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2264065-B1 | NOVEL INSULIN DERIVATIVES | NOVO NORDISK AS (DK) | 2017-03-08 | — | — | EP | disclosed |
| US-20140349925-A1 | NOVEL INSULIN DERIVATIVES | NOVO NORDISK AS (DK) | 2014-11-27 | — | — | US | disclosed |
| US-8828923-B2 | Insulin derivatives | NOVO NORDISK A/S (DK) | 2014-09-09 | — | — | US | disclosed |
| EP-2275439-B1 | Novel insulin derivatives | NOVO NORDISK AS (DK) | 2014-03-26 | — | — | EP | disclosed |
| EP-2107069-B1 | Novel insulin derivatives | NOVO NORDISK AS (DK) | 2013-01-16 | — | — | EP | disclosed |
| EP-2287184-A2 | Novel insulin derivatives | NOVO NORDISK A/S (DK) | 2011-02-23 | — | — | EP | disclosed |
| EP-2275439-A2 | Novel insulin derivatives | NOVO NORDISK A/S (DK) | 2011-01-19 | — | — | EP | disclosed |
| EP-2264065-A2 | Novel Insulin Derivatives | NOVO NORDISK A/S (DK) | 2010-12-22 | — | — | EP | disclosed |
| EP-2264066-A2 | Novel insulin derivatives | NOVO NORDISK A/S (DK) | 2010-12-22 | — | — | EP | disclosed |
| US-20100009899-A1 | Novel Insulin Derivatives | NOVO NORDISK A/S (DK) | 2010-01-14 | — | — | US | disclosed |
| US-7615532-B2 | Antidiabetic agents; insulin derivatives which are naturally occurring insulins or analogues thereof which have a side chain attached either to the alpha-amino group of the N-terminal amino acid residue of the B chain or to epsilon-amino group of a Lys residue present in the B chain of parent insulin | NOVO NORDISK A/S (DE) | 2009-11-10 | — | — | US | disclosed |
| EP-2107069-A2 | Novel insulin derivatives | NOVO NORDISK A/S (DK) | 2009-10-07 | — | — | EP | disclosed |
| US-20060183668-A1 | Antidiabetic agents; insulin derivatives which are naturally occurring insulins or analogues thereof which have a side chain attached either to the alpha-amino group of the N-terminal amino acid residue of the B chain or to epsilon-amino group of a Lys residue present in the B chain of parent insulin | NOVO NORDISK A/S (DK) | 2006-08-17 | — | — | US | disclosed |
| EP-1660531-A2 | NOVEL INSULIN DERIVATIVES | NOVO NORDISK A/S (DK) | 2006-05-31 | — | — | EP | disclosed |
| WO-2005012347-A2 | NOVEL INSULIN DERIVATIVES | NOVO NORDISK A/S (DK) | 2005-02-10 | — | — | WO | disclosed |